High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up. (Q40327997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

Yee T

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Barakos JA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Knight RT

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

Western Journal of Medicine

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

112-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in the diagnosis and treatment of cerebral cysticercosis

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Long-term results of praziquantel therapy in neurocysticercosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Selective indications for the use of praziquantel in the treatment of brain cysticercosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Neurocysticercosis: parasitology, clinical presentation, diagnosis, and recent advances in management.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Cerebral cysticercosis: documentation of natural history with CT.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Cysticercosis and cerebrovascular disease: a review

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Therapy for neurocysticercosis: a reappraisal.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Large cerebral infarction during praziquantel therapy in neurocysticercosis.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Neurocysticercosis in Houston, Texas. A report of 112 cases.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Therapy of parenchymal brain cysticercosis with praziquantel.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Neurocysticercosis: surgical and medical management with praziquantel.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

MR imaging in neurocysticercosis: a study of 56 cases

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

The course of seizures after treatment for cerebral cysticercosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Praziquantel in the treatment of neurocysticercosis: long-term follow-up.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1305452

Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial

20 August 2018

1 reference

12 December 2020

Short course of albendazole therapy for neurocysticercosis

1 reference

12 December 2020

Neurocysticercosis: an update

1 reference

12 December 2020

Lacunar syndrome due to neurocysticercosis

1 reference

12 December 2020

High-dose praziquantel for neurocysticercosis: efficacy and tolerability

1 reference

12 December 2020

Albendazole therapy for human neurocysticercosis, a controlled study with computerized tomography and magnetic resonance

1 reference

12 December 2020

1 reference

12 December 2020

Medical treatment of cysticercosis--ineffective

1 reference

12 December 2020

Medical treatment of cysticercosis--effective.

1 reference

12 December 2020

Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases

1 reference

12 December 2020

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

12 December 2020

Administration of praziquantel in neurocysticercosis

1 reference

12 December 2020

Praziquantel: a major advance in anthelminthic therapy

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10063399%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

10063399

1 reference